BIOT — Bioter SA Income Statement
0.000.00%
Last trade - 00:00- €3.45m
- €192.75m
- €1.26m
Annual income statement for Bioter SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.228 | 0.246 | 0.252 | 0.499 | 1.25 |
| Cost of Revenue | |||||
| Gross Profit | -1.45 | -0.935 | -0.015 | -0.048 | 0.958 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | -16.7 | 0.197 | 0.188 | 2.35 | 12.6 |
| Operating Profit | 16.9 | 0.049 | 0.064 | -1.85 | -11.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6.94 | -8.8 | -9.45 | -12 | -22.1 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 5.92 | -8.82 | -9.66 | -11.8 | -21.1 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.06 | -8.81 | -9.68 | -11.7 | -21.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.06 | -8.81 | -9.68 | -11.7 | -21.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.345 | -0.539 | -0.606 | -0.698 | -1.27 |